文献速递肾移植肾小球疾病

供肾意外IgA沉积的患病率、特征与结局

Prevalence, Characteristics, and Outcomes of Incidental IgA Glomerular Deposits in Donor Kidneys.
PubMed 文献 · Kidney Int Rep · 2020-08-26

该研究在美国大型移植中心调查802例供肾移植后即刻活检(T0)中意外IgA沉积的情况。结果显示20.4%的T0活检存在系膜区IgA沉积,活体供肾和 deceased 供肾分别为13.2%和24.5%。尽管IgA+肾脏受者早期排斥及排斥相关移植物丢失更常见,但5年肾功能和移植物存活率与无IgA肾脏相当。

要点

  • 供肾T0活检中意外IgA沉积并不少见,约占20.4%。
  • IgA沉积强度与系膜病理相关,高强度沉积清除率更低。
  • 供肾IgA沉积未对5年移植物或患者存活产生不利影响。

核心结论

  • 供肾意外IgA沉积与移植物或患者生存无 adverse 关联。
  • 供肾IgA是否代表潜在IgA肾病尚不确定,活体供者T0活检有IgA者需仔细随访。

研究设计与样本

  • 在美国大型移植中心对种族多样人群进行的研究,纳入802例供肾T0活检,包括活体供肾和 deceased 供肾。
  • 分析T0活检中意外IgA的存在与移植后患者及移植物结局的关系。

主要发现

  • 802例T0活检中系膜区IgA阳性占20.4%,活体供肾和 deceased 供肾分别为13.2%和24.5%。
  • 有意外IgA沉积的供者更可能患有高血压,且更常见于西班牙裔或亚裔。
  • IgA染色强度为1+、2+、3+的T0 IgA+活检分别占57.3%、26.8%、15.8%。
  • 系膜病理与更高强度IgA染色相关,随访时清除率更低(53.8% vs 无系膜病理者79.2%)。
  • 1+、2+、3+ IgA染色随访活检的清除率分别为91%、63%、40%。

临床怎么用

  • 供肾T0活检发现IgA沉积时,可结合染色强度和系膜病理评估清除可能性。
  • 活体供者T0活检显示IgA时,应进行仔细随访。

局限性

  • 供肾IgA是否代表潜在IgA肾病尚不确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Incidental IgA deposits in donor kidneys have unknown sequelae and may predate clinical kidney disease if primed by adverse immunologic or hemodynamic stimuli or may remain dormant. METHODS: The presence of incidental IgA in post-implantation (T0) biopsies from living (LDK) and deceased donor (DDK) kidneys, and its relationship to post-transplant patient and graft outcomes was investigated in an ethnically diverse US population at a large transplant center. RESULTS: Mesangial IgA was present in 20.4% of 802 T0 biopsies; 13.2% and 24.5% of LDK and DDK, respectively. Donors with incidental IgA deposits were more likely to have hypertension and be of Hispanic or Asian origin. Intensity of IgA staining was 1+ (57.3%), 2+ (26.8%), or 3+ (15.8%) of the T0 IgA+ biopsies. Mesangial pathology correlated with higher-intensity IgA staining with less clearance on follow-up (53.8%) versus 79.2% without mesangial pathology. IgA cleared in 91%, 63%, and 40% of follow-up biopsies with 1+, 2+, and 3+ IgA staining, respectively. Early post-transplant rejection and rejection-related graft loss occurred more frequently in IgA+ kidney recipients; however, 5-year kidney function and graft survival were comparable to kidneys without IgA. CONCLUSION: This first and largest report of incidental IgA in T0 biopsies of LDK and DDK in a US ethnically diverse population demonstrated no adverse association between the presence of IgA in donor kidneys and graft or patient survival. Whether IgA in donor kidneys represents latent IgA nephropathy (IgAN) is uncertain; nevertheless, living donors who demonstrate IgA on T0 biopsy deserve careful follow-up.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Gaber LW, Khan FN, Graviss EA, et al. Prevalence, Characteristics, and Outcomes of Incidental IgA Glomerular Deposits in Donor Kidneys. Kidney Int Rep. 2020. PMID: 33163712. doi:10.1016/j.ekir.2020.08.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。